NANTAHALA CAPITAL MANAGEMENT, LLC – Merrimack Pharmaceuticals, Inc. Transaction History
NANTAHALA CAPITAL MANAGEMENT, LLC portfolio value:
$1.61M
portfolio value
NANTAHALA CAPITAL MANAGEMENT, LLC quarter portfolio value change:
-36.97%
quarter
Merrimack Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.60% | -61.91K shares | -1.31M | $3.75 | 429.59K |
| Q2 2022 | share | Decrease | -4.90% | -25.30K shares | -345K | $5.95 | 491.50K |
| Q1 2022 | share | Decrease | -9.33% | -53.15K shares | 1.04M | $6.33 | 516.81K |
| Q4 2021 | share | 0.00% | 0 shares | -524K | $3.93 | 569.97K | |
| Q3 2021 | share | Decrease | -0.35% | -1.97K shares | -902K | $4.83 | 569.97K |
| Q2 2021 | share | Decrease | -6.08% | -37.02K shares | -169K | $6.39 | 571.94K |
| Q1 2021 | share | Decrease | -19.00% | -142.86K shares | -1.35M | $6.28 | 608.97K |
| Q4 2020 | share | Decrease | -0.01% | -100 shares | 2.17M | $6.89 | 751.84K |
| Q3 2020 | share | Increase | +0.58% | 4.30K shares | 518K | $4 | 751.94K |
| Q2 2020 | share | 0.00% | 0 shares | 883K | $3.33 | 747.63K | |
| Q1 2020 | share | 0.00% | 0 shares | -748K | $2.15 | 747.63K | |
| Q4 2019 | share | 0.00% | 0 shares | -1.00M | $3.15 | 747.63K | |
| Q3 2019 | share | Decrease | -9.17% | -75.51K shares | -554K | $3.98 | 747.63K |
| Q2 2019 | share | Increase | 0.00% | 823.14K shares | 3.91M | $3.32 | 823.14K |